As demonstrated by Samimi et al., CD8+ T-cells may additionally have antitumor activity in virus-negative MCC through their recognition of the melanoma-associated antigen 3, which is often expressed in MCC [58]. The gene discussed is CD8A; the disease is Merkel cell skin cancer.